Please login to the form below

Not currently logged in

Excellence in Collaboration and Partnerships

Back to categories

Judging criteria:

Clarity of situation analysis and unmet patient needs (10)

  • Demonstrate how you gained deep and meaningful insights into customer needs and partner’s/partners’ objectives

Clarity and appropriateness of objectives (10)

  • Demonstrate how your objectives related to all stakeholders and reinforced each other
  • Shared objectives, showing rigour and ambition

Quality of strategy development based on insights (15)

  • Clearly demonstrate how you aimed to address yours and partner’s/partners’ needs in your strategy to improve health outcomes
  • Demonstrate what specific insights led to your choice of particular strategy

Quality of execution (10)

  • Demonstration of partnership between two or more stakeholders
  • Pooled skills, resources and experience

Quality of measurement and learning (10)

  • Demonstrate how metrics have been applied to measure outcomes, take further action and enable learning
  • Demonstrate how data captured is being
    leveraged and used to adapt strategy and tactics on an ongoing basis

Scalable (10)

  • Evidence of scalability across the appropriate geographic area

Evidence of improved health outcomes and value (15)

  • Evidence of customer engagement and positive supportive statements from HCPs
  • Evidence of changed perceptions and behaviours that will deliver improved health outcomes

Providers of healthcare services and support (such as patient groups) around the world (such as the NHS in the UK), social care services and the pharmaceutical industry share a common agenda to improve patient care outcomes through high-quality, cost-effective treatment and management.

The common agenda is to improve patient outcomes through joint working to ensure that patients get optimal care, with support to help them maximise the benefits of treatment across health and social care. These may be national, international or regional initiatives.

Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery/improved outcomes. These may have operated at a regional, national or international level.

Potential entrants might include:

  • Pharmaceutical, biotech, ethical life science, OTC and
    medical device/diagnostic company communications teams
  • Pharmaceutical company communications teams
  • Healthcare agencies and consultancies.
  • Providers of healthcare services and support around
    the world (such as the NHS/Department of Health in the UK.

This category relates to work carried out between January 2019 and June 2020.


Back to categories


PMEA Awards 2020

Key dates

Entry deadline 27 August 2020
Extended entry deadline 3 September 2020*
*additional fee applies
Judging Day 1 October 2020
Company of the Year Interviews 22 October 2020
PMEA Event 25 November 2020